Next-Generation Surgical Mesh System for Personalized Soft Tissue Repair

A revolutionary surgical mesh system that integrates advanced materials, sensors, and bioactive agents to facilitate personalized soft tissue repair, enabling minimally invasive procedures, improved healing outcomes, and reduced defect recurrence.

The original segmented skirted surgical mesh patent, while effective, has limitations in terms of adaptability, biocompatibility, and healing promotion. The new inventive concept addresses these limitations by introducing a modular, sensor-enabled, and biohybrid approach that can be customized to specific defect geometries and patient needs.

The next-generation surgical mesh system comprises a base layer of surgical mesh with a self-healing material, and a segmented skirt of surgical mesh with adjustable segments that can be customized to fit specific defect geometries. The system can be infused with bioactive agents that promote tissue regeneration and may include integrated sensors for monitoring tissue healing. The modular design allows for interchangeable segmented skirts with varying geometries and materials to accommodate different defect types. Additionally, a computer-aided design system utilizing machine learning algorithms can generate customized mesh designs based on patient-specific defect geometries and tissue characteristics.

The new claims introduce a paradigm shift in surgical mesh technology by integrating advanced materials, sensors, and bioactive agents to facilitate personalized soft tissue repair. The inventive step lies in the combination of these features, which enables minimally invasive procedures, improved healing outcomes, and reduced defect recurrence.

Alternative embodiments may include the use of different self-healing materials, varying segmented skirt geometries, and alternative bioactive agents. Additionally, the system could be adapted for use in other medical applications, such as wound healing or tissue engineering.

The next-generation surgical mesh system has significant commercial potential in the medical device industry, particularly in the areas of soft tissue repair, wound healing, and tissue engineering. The target market includes hospitals, surgical centers, and medical research institutions, with potential for expansion into new markets and applications.